Osaka Biotech & Pharma Networking Event 2024
It is a partnering event with Osaka, Japan companies in collaboration with clusters & public agencies in Canada, UK. You can also learn about local ecosystem throgh online presentation by each collaborating organization. Join us and expand your global network!
※日本語のご案内は こちら.
■For your registration:
|
■Event outline
Type | Online |
Date | 25 November – 6 December 2024 |
Program |
1. Networking and 1on1 meeting with overseas companies.
You will be provided a profile page on the platform to promote your busness, technology, assets and etc. When you are interested in others profile, you can communicate with them through short message system or video call on the event platform. 2. Learning about local ecosystem through online presentation.
Through the online presentation you can learn about local companies, institutions, soft-landing support and ecosystem directly from each collaborating organization. You can also contact to them by short message system or video call. |
Participation Fee | Free of charge |
Language | English |
Flyer | Click here to donwload. |
Target fields |
1. Drug discovery, Drug discovery support including AI-assisted drug development
2. Digital Therapeutics such as drug-device combinations, non-pharmacological therapy systems
3. Regenerative medicine
|
Target participants |
Representatives of enterprises, research and educational institutions and other related organisations active in the above target fields.
1. Companies approved by collaborating organizations
2. Companies in Japan
3. Companies that participated last year in Australia, New Zealand, UK, Switzerland and Canada
|
■Collaborating organizations
Region | Collaborating organization | Logo |
Canada・Ontario | Government of Ontario | |
Canda・Quebec | Government of Quebec | |
UK・Scottland | Scottish Development International | |
UK・Northen Ireland | Invest Northern Ireland | |
UK・Wales | Welsh Government |
■Organizer & Contact
Organizer: Osaka Prefectural Government
Contact: Life Sciences Industry Division
■Supported by
To be updated